Braveheart Bio, Inc.(BRVE:US)
Market Cap$1.43B
Key Metrics
Price$19.55
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$80.58M
Total Assets$81.88M
Net Assets-$78.39M
Total Debt$667K
Key Metrics
Price$19.55
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$80.58M
Total Assets$81.88M
Net Assets-$78.39M
Total Debt$667K
Financials
| Name | Jun 30, 2026 | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Cost of Revenue | - | - | - |
Gross Profit | - | - | - |
| $15.88M | $15.05M | $5K | |
| Research and Development | $11.13M | $10.91M | $0 |
| Selling, General, and Administrative | $4.76M | $4.14M | $5K |
| Other Operating Expenses | - | - | - |
Operating Income | -$15.88M | -$15.05M | -$5K |
| $894K | $769K | -$94K | |
| Non-Operating Interest Income | $889K | $771K | $0 |
| Non-Operating Interest Expense | - | - | - |
| Other Income/Expense | $5K | -$2K | -$94K |
Income Before Tax | -$14.99M | -$14.28M | -$99K |
Income Tax | - | - | - |
Net Income | -$14.99M | -$14.28M | -$99K |
Minority Interests | - | - | - |
Preferred Stock Dividends | - | - | - |
Net Income to Common | -$14.99M | -$14.28M | -$99K |
Shares Outstanding (Basic) | 73.15M | - | - |
Shares Outstanding (Diluted) | 73.15M | - | - |
EPS (Basic) | -$0.25 | - | - |
EPS (Diluted) | -$0.25 | - | - |
EBIT | -$15.88M | -$15.05M | -$5K |
EBITDA | -$15.88M | -$15.05M | $89K |